Literature DB >> 11743041

The value of electron microscopy in the diagnosis of chronic renal allograft rejection.

B Ivanyi1, E Kemeny, E Szederkenyi, F Marofka, P Szenohradszky.   

Abstract

The main causes of the late dysfunction of renal allografts are chronic rejection and chronic transplant nephropathy. Both are clinicopathologic entities, with a similar clinical presentation, but different histologic appearances. Chronic rejection is characterized by the presence of alloantigen-induced lesions (transplant arteriopathy and transplant glomerulopathy), and chronic transplant nephropathy by nonspecific sclerosing changes. The incidence of transplant arteriopathy and transplant glomerulopathy is relatively low. Electron microscopy (EM) may overcome the limitations in the histologic diagnosis of chronic rejection, because it verifies alloantigen-induced chronic microvasculopathy in the peritubular capillaries (transplant capillaropathy), and identifies transplant glomerulopathy more precisely than does light microscopy. To assess the value of EM in chronic rejection diagnosis, a retrospective search for transplant capillaropathy and transplant glomerulopathy was performed in a consecutive series of 91 biopsies performed > or = 6 months after implantation (median: 26 months, range 6-186) and the diagnoses were reclassified on the basis of the ultrastructural findings. The definitions used were: transplant capillaropathy: a peritubular capillary profile with seven or more circumferential basement membrane layers, or at least three profiles with five or six circumferential layers; ultrastructurally verified transplant glomerulopathy: thickening of the capillary wall in at least three loops in consequence of the widening of the subendothelial space by abnormal basement membrane material, and the formation of a new layer(s) of basal lamina; and chronic rejection: the presence of transplant capillaropathy and/or transplant glomerulopathy and/or transplant arteriopathy. Histologically, chronic transplant nephropathy, chronic rejection, chronic cyclosporine nephrotoxicity, glomerulonephritis, acute rejection, "suspicious" for acute rejection, and "others" were diagnosed in 37%, 34%, 21%, 19%, 57%, 30%, and 5% of the specimens, respectively. The results of EM increased the diagnosis of chronic rejection to 69% of the cases, and decreased chronic transplant nephropathy to 15%. The individual incidence of transplant capillaropathy and transplant glomerulopathy was 79% and 57%, respectively, and their cumulative incidence was 92%. Five biopsies exhibited merely transplant arteriopathy. A late dysfunction typically had more than one cause; the most frequent combination was chronic rejection and acute rejection. In conclusion, the EM search for transplant capillaropathy and transplant glomerulopathy doubled the frequency of the diagnosis of chronic rejection. Currently, the evaluation of renal allograft biopsies from recipients with a late dysfunction relies on standard light microscopy. Because light microscopy per se proved to be insensitive in the diagnosis of chronic rejection, incorporation of EM into the evaluation of late dysfunction biopsies is strongly recommended.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11743041     DOI: 10.1038/modpathol.3880461

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  11 in total

1.  Contribution of electron microscopy to the final diagnosis of renal biopsies in Egyptian patients.

Authors:  Nadia Galal Elhefnawy
Journal:  Pathol Oncol Res       Date:  2010-07-20       Impact factor: 3.201

2.  Peritubular capillary basement membrane changes in chronic renal allograft rejection: Comparison of light microscopic and ultrastructural observations.

Authors:  Bela Ivanyi; Eva Kemeny; Peter Rago; Norbert Lazar; Krisztina Boda; Zita Morvay; Pal Szenohradszky; Edit Szederkenyi
Journal:  Virchows Arch       Date:  2011-07-01       Impact factor: 4.064

3.  Diagnostic significance of peritubular capillary basement membrane multilaminations in kidney allografts: old concepts revisited.

Authors:  George Liapis; Harsharan K Singh; Vimal K Derebail; Adil M H Gasim; Tomasz Kozlowski; Volker Nickeleit
Journal:  Transplantation       Date:  2012-09-27       Impact factor: 4.939

4.  Morphologic Features and Clinical Impact of Arteritis Concurrent with Transplant Glomerulopathy.

Authors:  Deján Dobi; Zsolt Bodó; Éva Kemény; Krisztina Boda; Pál Szenohradszky; Edit Szederkényi; Zoltan G Laszik; Béla Iványi
Journal:  Pathol Oncol Res       Date:  2015-07-23       Impact factor: 3.201

5.  Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: a cross-sectional study.

Authors:  Amir Soltani; David W Reid; Sukhwinder S Sohal; Richard Wood-Baker; Steve Weston; H Konrad Muller; E Haydn Walters
Journal:  Respir Res       Date:  2010-07-30

6.  Peritubular capillary basement membrane multilayering in early and advanced transplant glomerulopathy: quantitative parameters and diagnostic aspects.

Authors:  Deján Dobi; Zsolt Bodó; Éva Kemény; László Bidiga; Zoltán Hódi; Pál Szenohradszky; Edit Szederkényi; Anikó Szilvási; Béla Iványi
Journal:  Virchows Arch       Date:  2016-09-07       Impact factor: 4.064

Review 7.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

8.  Association between depression and glycemic control among type 2 diabetes patients in Lima, Peru.

Authors:  Brenda Crispín-Trebejo; María Cristina Robles-Cuadros; Antonio Bernabé-Ortiz
Journal:  Asia Pac Psychiatry       Date:  2015-06-02       Impact factor: 2.538

Review 9.  Biological pathways and potential targets for prevention and therapy of chronic allograft nephropathy.

Authors:  Badri Man Shrestha; John Haylor
Journal:  Biomed Res Int       Date:  2014-05-27       Impact factor: 3.411

10.  Aortic valve calcification: a bone of contention.

Authors:  Sergio Bertazzo; Eileen Gentleman
Journal:  Eur Heart J       Date:  2017-04-21       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.